These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Unraveling divergent gene expression profiles in bicuspid and tricuspid aortic valve patients with thoracic aortic dilatation: the ASAP study. Folkersen L, Wågsäter D, Paloschi V, Jackson V, Petrini J, Kurtovic S, Maleki S, Eriksson MJ, Caidahl K, Hamsten A, Michel JB, Liska J, Gabrielsen A, Franco-Cereceda A, Eriksson P. Mol Med; 2011; 17(11-12):1365-73. PubMed ID: 21968790 [Abstract] [Full Text] [Related]
5. Focus on the unique mechanisms involved in thoracic aortic aneurysm formation in bicuspid aortic valve versus tricuspid aortic valve patients: clinical implications of a pilot study. Balistreri CR, Pisano C, Candore G, Maresi E, Codispoti M, Ruvolo G. Eur J Cardiothorac Surg; 2013 Jun; 43(6):e180-6. PubMed ID: 23248206 [Abstract] [Full Text] [Related]
7. Identification of immune-related signatures and pathogenesis differences between thoracic aortic aneurysm patients with bicuspid versus tricuspid valves via weighted gene co-expression network analysis. Huang M, Guan R, Qiu J, Gnamey AJE, Wang Y, Tian H, Sun H, Shi H, Sun W, Jia X, Wu J. PLoS One; 2023 Jun; 18(10):e0292673. PubMed ID: 37883426 [Abstract] [Full Text] [Related]